Literature DB >> 15811213

Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes.

Marc Cohen1.   

Abstract

OBJECTIVE: The aim of this review was to collate the published evidence on independent predictors of bleeding and late mortality in acute coronary syndrome (ACS) patients, to compare the two sets of risk factors, and to investigate whether bleeding is reported as a predictor of late mortality. RESEARCH DESIGN AND METHODS: Computerized searches, covering the period from 1999 to July 2004, were performed on MEDLINE, EMBASE, and the Cochrane Library database. Studies were eligible for inclusion in the review if they related to patients with ACS and included an assessment of risk factors for bleeding, mortality, or both. Studies that did not meet these criteria were excluded. MAIN OUTCOME MEASURES: A total of 937 studies were retrieved, of which 912 were excluded from the review because they did not meet the defined criteria.
RESULTS: The available evidence suggests that any impact of bleeding on mortality is confined to the short term. In studies that showed a significant association between bleeding and risk of mortality, association between bleeding and risk of mortality, this was always related to in-hospital or 30-day mortality. By contrast, studies of long-term mortality consistently showed that bleeding was not an independent predictor. Furthermore, follow-up studies showed that adverse outcomes in hospital and within the first month were not related to 1-year mortality. This may reflect the beneficial impact of anticoagulant therapy on subsequent cardiovascular risk in patients with ACS, which outweighs any shortterm detrimental effect of bleeding.
CONCLUSIONS: The available evidence suggests that any impact of bleeding on mortality in ACS patients appears to be confined to the short term, and long-term outcomes do not reflect the impact of in-hospital bleeding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811213     DOI: 10.1185/030079905X30725

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  6 in total

Review 1.  Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.

Authors:  David H Fitchett; Bjug Borgundvaag; Warren Cantor; Eric Cohen; Sanjay Dhingra; Stephen Fremes; Milan Gupta; Michael Heffernan; Heather Kertland; Mansoor Husain; Anatoly Langer; Eric Letovsky; Shaun G Goodman
Journal:  Can J Cardiol       Date:  2006-06       Impact factor: 5.223

2.  Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock.

Authors:  Mohit Pahuja; Sagar Ranka; Omar Chehab; Tushar Mishra; Emmanuel Akintoye; Oluwole Adegbala; Ahmed S Yassin; Tomo Ando; Katherine L Thayer; Palak Shah; Carey D Kimmelstiel; Payam Salehi; Navin K Kapur
Journal:  Catheter Cardiovasc Interv       Date:  2020-05-30       Impact factor: 2.692

Review 3.  The impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the risk.

Authors:  David Fitchett
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

4.  Early use of omeprazole benefits patients with acute myocardial infarction.

Authors:  Qian-Ping Gao; Yan Sun; Yu-Xue Sun; Lan-Feng Wang; Lu Fu
Journal:  J Thromb Thrombolysis       Date:  2008-10-02       Impact factor: 2.300

5.  Outcome of 1051 Octogenarian Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Observational Cohort From the London Heart Attack Group.

Authors:  Daniel I Bromage; Daniel A Jones; Krishnaraj S Rathod; Claire Grout; M Bilal Iqbal; Pitt Lim; Ajay Jain; Sundeep S Kalra; Tom Crake; Zoe Astroulakis; Mick Ozkor; Roby D Rakhit; Charles J Knight; Miles C Dalby; Iqbal S Malik; Anthony Mathur; Simon Redwood; Philip A MacCarthy; Andrew Wragg
Journal:  J Am Heart Assoc       Date:  2016-06-27       Impact factor: 5.501

6.  Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany.

Authors:  Ulrike Theidel; Christian Asseburg; Evangelos Giannitsis; Hugo Katus
Journal:  Clin Res Cardiol       Date:  2013-03-09       Impact factor: 5.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.